Pfizer-BioNTech Still Immune From Lawsuits Over COVID-19 Vaccine After Federal Approval: Lawyers

Pfizer-BioNTech Still Immune From Lawsuits Over COVID-19 Vaccine After Federal Approval: Lawyers
A vial labeled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken on March 19, 2021. Dado Ruvic/Illustration/Reuters
Meiling Lee
Updated:

The Food and Drug Administration’s (FDA) recent approval of the messenger RNA COVID-19 vaccine Comirnaty has prompted a wave of vaccine mandates across the country, yet individuals who happen to suffer serious side effects won’t be able to file a lawsuit against the producer of the vaccine, according to lawyers.

Comirnaty was fully approved on Aug. 23 for people 16 and older. However, the fact sheet for recipients and caregivers states that the vaccine is “also authorized under EUA [emergency use authorization]” for children aged 12 to 15 and for those in the same adolescent population requiring a third dose.